A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)
An Open-Label Pilot Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Potential of Oral Insulin to Reduce Liver Fat Content and Fibrosis in Patients With Nonalcolholic Steatohepatitis (NASH)
Sponsor: Hadassah Medical Organization
A PHASE2 clinical study on Non-Alcoholic Steatohepatitis (NASH) and Type2 Diabetes Mellitus, this trial is completed. The trial is conducted by Hadassah Medical Organization and has accumulated 16 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2021 — Apr 2024 [monthly]
Completed PHASE2
-
Oct 2021 — Dec 2021 [monthly]
Completed PHASE2
Status: Recruiting → Completed
▶ Show 11 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE2
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Jun 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Jan 2019 — Jun 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Aug 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
-
May 2017 — Mar 2018 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hadassah Medical Organization
- Oramed, Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .